FDA Inspection 1242486 — Ningbo Renjian Pharmaceutical Group Co., Ltd
The FDA completed an inspection of Ningbo Renjian Pharmaceutical Group Co., Ltd on May 17, 2024 in Ningbo. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 17, 2024
- Fiscal Year
- 2024
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Ningbo (China)